These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2455709)

  • 1. Relief of respiratory distress with leukapheresis in a child with chronic myelocytic leukemia.
    Moxey-Mims MM; Luban NL; Bock GH; Ruley EJ; Preston KM
    J Clin Apher; 1988; 4(1):47-9. PubMed ID: 2455709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects on immunity of multiple leukapheresis using a rapidly excreted analog of hydroxyethyl starch.
    Strauss RG; Goeken JA; Imig KM; Greazel C
    Transfusion; 1986; 26(3):265-8. PubMed ID: 2422796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on low-dose hydroxyethyl starch leukapheresis. Rate of elimination of HES in vivo and function of the harvested granulocytes in vitro.
    Szymanski IO; Teno RA; Gandhi JG; Newburger PE
    Vox Sang; 1984; 47(5):325-9. PubMed ID: 6209854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Donor reaction to hydroxyethyl starch during granulocytapheresis.
    Dutcher JP; Aisner J; Hogge DE; Schiffer CA
    Transfusion; 1984; 24(1):66-7. PubMed ID: 6198788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new method to collect granulocytes using a low dose of hydroxyethyl starch.
    Szymanski IO
    Vox Sang; 1983; 44(2):106-14. PubMed ID: 6187130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response to chronic leukapheresis procedures and survival of chronic myelogenous leukemia patients.
    Hester JP; McCredie KB; Freireich EJ
    Transfusion; 1982; 22(4):305-7. PubMed ID: 6179267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multicenter trial to document the efficacy and safety of a rapidly excreted analog of hydroxyethyl starch for leukapheresis with a note on steroid stimulation of granulocyte donors.
    Strauss RG; Hester JP; Vogler WR; Higby DJ; Snikeris AC; Imig KM; Greazel C; Mallard G; Burnett D; Gupta S
    Transfusion; 1986; 26(3):258-64. PubMed ID: 2422795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro comparison of the erythrocyte sedimenting properties of dextran, hydroxyethyl starch and a new low-molecular-weight hydroxyethyl starch.
    Strauss RG
    Vox Sang; 1979; 37(5):268-71. PubMed ID: 93347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic granulocyte leukemia with respiratory distress. Efficacy of emergency leukapheresis.
    Karp DD; Beck JR; Cornell CJ
    Arch Intern Med; 1981 Sep; 141(10):1353-4. PubMed ID: 6943985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alternate dosage regimens for high molecular weight hydroxyethyl starch.
    Rock G; McCombie N
    J Clin Apher; 1985; 2(4):375-7. PubMed ID: 2415507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selecting the optimal dose of low-molecular-weight hydroxyethyl starch (Pentastarch) for granulocyte collection.
    Strauss RG; Villhauer PJ; Imig KM; Eckermann I; Gupta SD; Thomson DS
    Transfusion; 1987; 27(4):350-2. PubMed ID: 2440159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The elimination of hydroxyethyl starch from the blood donors experiencing single of multiple intermittent-flow centrifugation leukapheresis.
    Maguire LC; Strauss RG; Koepke JA; Bowman RJ; Zelenski KR; Lambert RM; Hulse JD; Atnip AK
    Transfusion; 1981; 21(3):347-53. PubMed ID: 6165109
    [No Abstract]   [Full Text] [Related]  

  • 13. Erythema multiforme following the infusion of hydroxyethyl starch.
    Klein RE; Mogollon G
    Transfusion; 1984; 24(2):166-7. PubMed ID: 6200969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternate dosage regimens for high-molecular-weight hydroxyethyl starch.
    Rock G; McCombie N
    Transfusion; 1985; 25(5):417-9. PubMed ID: 2413591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The plasma kinetics of hydroxyethyl starch 350/0.60: a potential new adjunct for centrifugal leucapheresis.
    Mishler JM
    Am J Hematol; 1979; 7(4):341-7. PubMed ID: 94771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological effects produced by the acute and chronic administration of hydroxyethyl starch.
    Mishler JM
    J Clin Apher; 1984; 2(1):52-62. PubMed ID: 6085628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donor toxicity in granulocyte collections: association of lichen planus with the use of hydroxyethyl starch leukapheresis.
    Bode U; Deisseroth AB
    Transfusion; 1981; 21(1):83-5. PubMed ID: 6162256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of hydroxyethyl starch in leukocytapheresis procedures does not increase renal toxicity.
    Pagano MB; Harmon C; Cooling L; Connelly-Smith L; Mann SA; Pham HP; Marques MB; Schlueter AJ; Case R; King KE; Cataife G; Wu Y; Wong EC; Winters JL
    Transfusion; 2016 Nov; 56(11):2848-2856. PubMed ID: 27600855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukapheresis of patients with chronic granulocytic leukemia (CGL), using the Haemonetics blood processor.
    Huestis DW; Price MJ; White RF; Inman M
    Transfusion; 1976; 16(3):255-60. PubMed ID: 59435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydroxyethyl starch serum levels in leukapheresis donors measured by modified periodic acid-Schiff staining technique.
    Trivedi SM; Humphrey RL; Braine HG; Frondoza CG
    Transfusion; 1984; 24(3):260-3. PubMed ID: 6203192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.